Literature DB >> 6360434

The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice.

G T Layton, A M Smithyman.   

Abstract

A double oral immunization (PO/PO) with an outer membrane protein (OMP) from a human uropathogenic strain of Escherichia coli, resulted in the partial protection of mice infected per urethrally with the same strain. Complete protection was achieved by immunizing with OMP in Freund's complete adjuvant (FCA), intramuscularly (i.m.), followed by an oral boost (i.m./PO). The PO/PO protocol stimulated mainly local urinary antibody synthesis, particularly IgA, whilst the i.m./PO regimen resulted in the appearance of both serum and urine antibodies. A single dose of OMP, 6 days after infection, rendered the mice resistant to reinfection, in contrast to non-immunized mice, and led to a significant increase in urine, serum and bile IgA anti-OMP levels. Our results confirm previous reports that the urinary tract forms part of the common mucosal immune system and provides further evidence for immunological memory in mucosal immunity. These results also demonstrate that our OMP preparation is a highly effective immunizing antigen, and that such preparations may be suitable as oral vaccines against urinary tract infection in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6360434      PMCID: PMC1535906     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

2.  Transport of oligomeric IgA of systemic origin into external secretions.

Authors:  G Virella; P C Montgomery; I M Lemaitre-Coelho
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

3.  Modulation of the immune response by a synthetic adjuvant and analogs.

Authors:  L Chedid; F Audibert; P Lefrancier; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

4.  Rapid disappearance from serum of intravenously injected rat myeloma IgA and its secretion into bile.

Authors:  G D Jackson; I Lemaître-Coelho; J P Vaerman; H Bazin; A Beckers
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

5.  Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs.

Authors:  N F Pierce; R B Sack; B K Sircar
Journal:  J Infect Dis       Date:  1977-06       Impact factor: 5.226

6.  The outer membrane proteins of Gram-negative bacteria: biosynthesis, assembly, and functions.

Authors:  J M DiRienzo; K Nakamura; M Inouye
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

7.  Immunoglobulin synthesis in lower urinary tract infection.

Authors:  W L Hand; J W Smith; T E Miller; J A Barnett; J P Sanford
Journal:  J Lab Clin Med       Date:  1970-01

8.  Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells.

Authors:  C S Edén; H A Hansson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

9.  Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells.

Authors:  C Svanborg-Edén; A M Svennerholm
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

10.  Rapid active transport of immunoglobulin A from blood to bile.

Authors:  E Orlans; J Peppard; J Reynolds; J Hall
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  7 in total

1.  Non-antibiotic prevention of urinary tract infection.

Authors:  L Hagberg; H Leffler; C Svanborg Edén
Journal:  Infection       Date:  1985       Impact factor: 3.553

2.  Secretory immune responses in human kidneys.

Authors:  C R Abramowsky; G L Swinehart
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

3.  Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies.

Authors:  John W Mapletoft; Laura Latimer; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

4.  Non-antibiotic prevention of urinary tract infection.

Authors:  L Hagberg; H Leffler; C Svanborg Edén
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

5.  Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.

Authors:  N Moayeri; C M Collins; P O'Hanley
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

Review 6.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

7.  Mucosal immunization with iron receptor antigens protects against urinary tract infection.

Authors:  Christopher J Alteri; Erin C Hagan; Kelsey E Sivick; Sara N Smith; Harry L T Mobley
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.